Vault-13

BIOCON LTD BIOS

COM · Common Stock · CUSIP Y0905C102

2 institutional holders +0 vs Q1 2024
1,349,5121.3m shares reported held*
$5.7mreported value*
0 new 0 added 1 reduced 0 sold out net sold ≈ $17.1k (-4.1k shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $4.21.

Trends to Q2 2024

Institutional holders

Managers reporting a position, each quarter

012Q1 23: 1Q2 23: 1Q3 23: 1Q4 23: 1Q1 24: 2Q2 24: 22Q1 23Q2 23Q3 23Q4 23Q1 24Q2 24
Numbers
QuarterHolders
Q1 20231
Q2 20231
Q3 20231
Q4 20231
Q1 20242
Q2 20242

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
202Q2 23: 0 bought or addedQ2 23: 1 cut or sold outQ2 23Q3 23: 0 bought or addedQ3 23: 1 cut or sold outQ3 23Q4 23: 0 bought or addedQ4 23: 1 cut or sold outQ4 23Q1 24: 2 bought or addedQ1 24: 0 cut or sold outQ1 24Q2 24: 0 bought or addedQ2 24: 1 cut or sold outQ2 24
Numbers
QuarterBought or addedCut or sold out
Q2 202301
Q3 202301
Q4 202301
Q1 202420
Q2 202401

Biggest buyers

None

Biggest sellers

Holders, Q2 2024

#ManagerLocationShares Value% of their portfolioChangeShares change
1 Stanley-Laman Group, Ltd. 0.48% of their portfolio Berwyn, PA 800,000800.0k $3.4m $3.4m 0.48% Unchanged
2 Boston Common Asset Management, LLC 0.06% of their portfolio BOSTON, MA 549,512549.5k $2.3m $2.3m 0.06% Reduced -4.1k -4,059